Intra-Cellular Therapies (ITCI) - Gross Margin

ITCI (Intra-Cellular Therapies, Inc.) - company brandmark

Intra-Cellular Therapies (ITCI) is reducing its reliance on a single drug by expanding the application of Caplyta for the treatment of CNS disorders. The gross margin percentage provided by the GURU.Markets system confirms this trend, and 91.60 shows the level of this metric. The company's revenues are based on the sale of treatments for bipolar depression, while drug production is fully outsourced to third-party contractors, maintaining control over patents.

ITCI: Intra-Cellular Therapies, Inc. Gross Margin 07/04/2022 - 04/13/2025

Comprehensive metric breakdowns and analytics for Intra-Cellular (ITCI)

- share price and consensus valuation forecast:
Summary company analysis:Intra-Cellular Therapies - ITCI
Manufactured products of Intra-Cellular Therapies Inc.

Intra-Cellular Therapies (ITCI) specializes in developing the innovative drug Caplyta for the treatment of psychiatric disorders. The gross margin here quantifies production efficiency by subtracting direct costs from total revenue to assess operational profitability. Growth in this metric confirms the business's ability to scale sales without a proportional increase in expenses, which is clearly reflected in the gross margin dynamics as the company moves toward profitability.

Direct competitors

Return on Gross Profit Biogen Corp|Return on Gross Profit NBIX|Regencell Corp (RGC) - Return on Sales by Gross Profit|Gross Margin AXSM|Return on Gross Profit ACADIA Pharmaceuticals ACAD|Gross Margin XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Gross Profitability Margin|SUPN - Gross Profitability|Catalyst Pharmaceuticals Inc (CPRX) - Return on Gross Profit|DNLI (Denali Corp) - Return on Gross Profit|Gross Profit Margin harmonybiosciences.com (HRMY)|Return on Gross Profit BHVN|Gross Margin Amylyx|Gross Margin TRVI|PRAX (Praxis Corp) - Gross Profit Rate|Gross Margin AVXL (anavex.com)|CBLL: Gross Return on Sales|PRTA - Gross Profitability|ALEC - Gross Margin|Annexon Inc. (ANNX) - Gross Profitability|Return on Gross Profit Omeros Corp|Return on Gross Profit NGNE|ACIU: Gross Profit Rate|Return on Gross Profit VYGR (Voyager Corp)|Return on Gross Profit Neumora NMRA|Gross Profitability Scilex Holding Company, Inc. SCLX|Gross Sales Margin Tevogen Bio Inc.|ACOG - Gross Profitability|Gross Sales Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Return on Gross Profit|Cassava Sciences Inc (SAVA) - Gross Margin|Return on Gross Profit ASRT|Gross Margin coyatherapeutics.com|Gross Margin VTGN|Ovid Therapeutics - Gross Return on Sales|Gross Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Return on Gross Profit|ATHE - Gross Profitability|Return on Sales by Gross Profit clene.com CLNN|PEPG: Gross Margin|Gross Return on Sales JUNS|RLMD (Relmada Corp) - Gross Margin|Annovis Bio Inc (ANVS) - Return on Sales by Gross Profit|Gross Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Gross Profit Rate|Gross Profitability Klotho Neurosciences KLTO|NRSN: Gross Return on Sales|RVPH: Return on Gross Profit|MTVA: Gross Profitability|NRXS (NeurAxis Inc) - Return on Gross Profit|Return on Gross Profit Helius Medical Technologies, Inc.|Gross Profitability Passage Bio Inc.|Gross Profit Margin bionomics.com.au NEUP|Gross Margin NERV|Gross Margin Athira Pharma Inc (ATHA)|Gross Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Gross Return on Sales|CYCN - Gross Profitability|Gross Profit Margin Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Return on Gross Profit|Gross Sales Margin Cortigent, Inc. CRGT|Gross Profitability Avenue Therapeutics, Inc.|Return on Gross Profit BrainStorm Cell Therapeutics Inc. (BCLI)|Gross Profitability Cara Therapeutics, Inc (CARA)|Gross Profitability CHRO (Chromocell Therapeutics Corp.)|Gross Margin ELYM (eliemtx.com)|LBPH: Gross Return on Sales|MRNS - Gross Profitability|NKGen Biotech, Inc. (NKGN) - Return on Gross Profit|neurobopharma.com (NRBO) - Gross Profitability|SAGE: Gross Profit Ratio|Gross Profitability Synaptogenix, Inc.|Gross Profitability TRVN|Gross Margin VIGL|Gross Margin anewmeds.com (WENA)|Gross Margin CERE (cerevel.com)